Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).

[1]  D. Murrell,et al.  Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis. , 2011, Dermatologic clinics.

[2]  D. Zillikens,et al.  Clinical and immunopathological spectrum of paraneoplastic pemphigus , 2010, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[3]  D. Zillikens,et al.  Rituximab in Severe Pemphigus , 2009, Annals of the New York Academy of Sciences.

[4]  V. Sehgal,et al.  Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome , 2009, International journal of dermatology.

[5]  Z. Miltényi,et al.  Successful Immunomodulatory Therapy in Castleman Disease with Paraneoplastic Pemphigus Vulgaris , 2009, Pathology & Oncology Research.

[6]  E. Berti,et al.  Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus , 2008, Expert review of clinical immunology.

[7]  A. Nanda,et al.  Paraneoplastic pemphigus in association with B‐cell lymphocytic leukemia and hepatitis C: favorable response to intravenous immunoglobulins and prednisolone , 2007, International journal of dermatology.

[8]  W. Lim,et al.  Paraneoplastic pemphigus resembling linear IgA bullous dermatosis , 2006, International journal of dermatology.

[9]  S. Brunet,et al.  Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  C. Herrero,et al.  Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone. , 2005, Acta dermato-venereologica.

[11]  F. d'Amore,et al.  Alemtuzumab‐induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment‐resistant B‐cell chronic lymphocytic leukaemia , 2004, European journal of haematology.

[12]  A. Koster,et al.  Follicular Non-Hodgkin's Lymphoma with Refractory Paraneoplastic Pemphigus: Case Report with Review of Novel Treatment Modalities , 2004, Leukemia & lymphoma.

[13]  A. Sinha,et al.  Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus. , 2003, Journal of drugs in dermatology : JDD.

[14]  L. Gergely,et al.  Successful Treatment of B Cell Chronic Lymphocytic Leukemia-Associated Severe Paraneoplastic Pemphigus with Cyclosporin A , 2003, Acta Haematologica.

[15]  L. Borradori,et al.  Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus , 2003, The British journal of dermatology.

[16]  J. Saurat,et al.  Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus. , 2001, Archives of dermatology.

[17]  P. Itin,et al.  Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL , 2001, American journal of hematology.

[18]  M. Pittelkow,et al.  Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. , 2001, Archives of dermatology.

[19]  P. Courville,et al.  Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. , 2000, Journal of the American Academy of Dermatology.

[20]  E. Billingsley,et al.  Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus , 2000, The British journal of dermatology.

[21]  M. Hertzberg,et al.  Hypercalcemia and adrenal insufficiency in a patient with myelofibrosis , 2000, American journal of hematology.

[22]  M. Hertzberg,et al.  Paraneoplastic pemphigus in two patients with B‐cell non‐Hodgkin's lymphoma: Significant responses to cyclophosphamide and prednisolone , 2000, American journal of hematology.

[23]  M. Grever,et al.  Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. , 1999, Journal of the American Academy of Dermatology.

[24]  M. Amagai,et al.  The new pemphigus variants. , 1999, Journal of the American Academy of Dermatology.

[25]  E. Bröcker,et al.  Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy. , 1999, European journal of dermatology : EJD.

[26]  V. Kesic,et al.  Retroperitoneal round‐cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoides‐like eruption , 1997, International journal of dermatology.

[27]  N. Korman,et al.  Paraneoplastic pemphigus: potential therapeutic effect of plasmapheresis , 1996, The British journal of dermatology.

[28]  M. Pittelkow,et al.  Paraneoplastic pemphigus: a case of prolonged survival. , 1994, Mayo Clinic proceedings.

[29]  Y. C. Liu,et al.  Paraneoplastic pemphigus: a report of three cases including one long-term survivor. , 1992, Journal of the American Academy of Dermatology.